Breaking News

Adare Pharma Solutions makes contract manufacturing acquisition

Adare has acquired Frontida BioPharm that is a vertically integrated CDMO focused on oral formulations

Lonza and signs agreement with VC for molecule development

Lonza's expertise and technology is hoped to accelerates timelines while mitigating risks of the development and ...

GreenLight Biosciences and Samsung Biologics announce RNA collaboration

The partnership aims to accelerate the production of GreenLight’s COVID-19 vaccine candidate for Phase III clinical ...

Glass or polymer? swissfillon and SiO2 collaborate to deliver the best of both worlds in high quality filling

Fill and finish CDMO swissfillon and material science company SiO2 gave a joint presentation at MC Live to explain how ...

INDENA: always at the forefront of CDMO services

In 2021, Indena proudly celebrated one hundred years of pharmaceutical excellence based on medicinal plants

WuXi Biologics completes first GMP run at 24,000L line of MFG5 facility

With its total 60,000L capacity, MFG5 has now supported manufacture of late-phase and commercial projects across ...

Driving biotherapeutic development with advanced molecule characterisation

Evaluating and characterising complicated protein structures and the therapeutic activity of advanced biotherapeutic ...

CordenPharma to invest $11m at German HPAPI facility

The installation of the CTD facility at Plankstadt is a response to customer demands and the recognition of gaps in ...

Samsung Biologics to provide CDMO service for Enzolytics mAb therapies

The CDMO will support IND filings for Enzolytics’ anti-HIV and anti-SARS-CoV-2 monoclonal antibodies

Biologics and specialty medicines: planning your packaging from clinic to launch (part I)

The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, ...

Taking a lifecycle approach to fill-finish success

Dr Kevin Robinson recently spoke to swissfillon founder and CEO, Daniel Kehl, and Business Development Director, Carole ...

Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality

Personalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with ...

Metrics Contract to assist ESSA on oral oncology drug development

“We are excited to partner with ESSA on a program that is ultimately intended to benefit cancer patients. Our focus ...

CN Bio launches oncology service for drug discovery

The service provides a means to explore the relationships between pharmacokinetics, pharmacodynamics (PK/PD) and ...